James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 5,700 shares at $75.72 ($430K) on 2018-12-06, disclosed to the SEC on 2018-12-07.
Open-market sale of $430k GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.75 | 300 | $22K | 5.1% |
| 2 | $75.29 | 1,596 | $120K | 28.0% |
| 3 | $75.29 | 1,596 | $120K | 28.0% |
| 4 | $75.72 | 1,104 | $84K | 19.5% |
| 5 | $75.72 | 1,104 | $84K | 19.5% |
| Total | $75.38 avg | 5,700 |
| $430K |
| 100% |
| Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-07-09 | $399K | — | Filing → |
| GHDX | SELL | 2019-06-10 | $61K | — | Filing → |